Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
Identifieur interne : 000875 ( PubMed/Corpus ); précédent : 000874; suivant : 000876Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
Auteurs : Claudia Vellozzi ; Shahed Iqbal ; Brock Stewart ; Jerome Tokars ; Frank DestefanoSource :
- American journal of public health [ 1541-0048 ] ; 2014.
English descriptors
- KwdEn :
- Adult, Age Factors, Aged, Female, Guillain-Barre Syndrome (epidemiology), Guillain-Barre Syndrome (etiology), Guillain-Barre Syndrome (prevention & control), Humans, Influenza A Virus, H1N1 Subtype, Influenza Vaccines (adverse effects), Influenza Vaccines (therapeutic use), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Life Tables, Male, Middle Aged, Pandemics (prevention & control), Pandemics (statistics & numerical data), Risk Factors, United States (epidemiology), Young Adult.
- MESH :
- chemical , adverse effects : Influenza Vaccines.
- geographic , epidemiology : United States.
- epidemiology : Guillain-Barre Syndrome, Influenza, Human.
- etiology : Guillain-Barre Syndrome.
- prevention & control : Guillain-Barre Syndrome, Influenza, Human, Pandemics.
- statistics & numerical data : Pandemics.
- chemical , therapeutic use : Influenza Vaccines.
- Adult, Age Factors, Aged, Female, Humans, Influenza A Virus, H1N1 Subtype, Life Tables, Male, Middle Aged, Risk Factors, Young Adult.
Abstract
We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.
DOI: 10.2105/AJPH.2013.301651
PubMed: 24524517
Links to Exploration step
pubmed:24524517Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.</title><author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name><affiliation><nlm:affiliation>Claudia Vellozzi, Shahed Iqbal, Brock Stewart, and Frank DeStefano are with the Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jerome Tokars is with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.</nlm:affiliation></affiliation></author><author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name></author><author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name></author><author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name></author><author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24524517</idno><idno type="pmid">24524517</idno><idno type="doi">10.2105/AJPH.2013.301651</idno><idno type="wicri:Area/PubMed/Corpus">000875</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000875</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.</title><author><name sortKey="Vellozzi, Claudia" sort="Vellozzi, Claudia" uniqKey="Vellozzi C" first="Claudia" last="Vellozzi">Claudia Vellozzi</name><affiliation><nlm:affiliation>Claudia Vellozzi, Shahed Iqbal, Brock Stewart, and Frank DeStefano are with the Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jerome Tokars is with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.</nlm:affiliation></affiliation></author><author><name sortKey="Iqbal, Shahed" sort="Iqbal, Shahed" uniqKey="Iqbal S" first="Shahed" last="Iqbal">Shahed Iqbal</name></author><author><name sortKey="Stewart, Brock" sort="Stewart, Brock" uniqKey="Stewart B" first="Brock" last="Stewart">Brock Stewart</name></author><author><name sortKey="Tokars, Jerome" sort="Tokars, Jerome" uniqKey="Tokars J" first="Jerome" last="Tokars">Jerome Tokars</name></author><author><name sortKey="Destefano, Frank" sort="Destefano, Frank" uniqKey="Destefano F" first="Frank" last="Destefano">Frank Destefano</name></author></analytic><series><title level="j">American journal of public health</title><idno type="eISSN">1541-0048</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Guillain-Barre Syndrome (epidemiology)</term><term>Guillain-Barre Syndrome (etiology)</term><term>Guillain-Barre Syndrome (prevention & control)</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Life Tables</term><term>Male</term><term>Middle Aged</term><term>Pandemics (prevention & control)</term><term>Pandemics (statistics & numerical data)</term><term>Risk Factors</term><term>United States (epidemiology)</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Guillain-Barre Syndrome</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Guillain-Barre Syndrome</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Guillain-Barre Syndrome</term><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Age Factors</term><term>Aged</term><term>Female</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Life Tables</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24524517</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1541-0048</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>4</Issue><PubDate><Year>2014</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of public health</Title><ISOAbbreviation>Am J Public Health</ISOAbbreviation></Journal><ArticleTitle>Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.</ArticleTitle><Pagination><MedlinePgn>696-701</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2105/AJPH.2013.301651</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">We sought to assess risk of Guillain-Barré syndrome (GBS) among influenza A (H1N1) 2009 monovalent (pH1N1) vaccinated and unvaccinated populations at the end of the 2009 pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We applied GBS surveillance data from a US population catchment area of 45 million from October 15, 2009, through May 31, 2010. GBS cases meeting Brighton Collaboration criteria were included. We calculated the incidence density ratio (IDR) among pH1N1 vaccinated and unvaccinated populations. We also estimated cumulative GBS risk using life table analysis. Additionally, we used vaccine coverage data and census population estimates to calculate denominators.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 392 GBS cases; 64 (16%) occurred after pH1N1vaccination. The vaccinated population had lower average risk (IDR = 0.83, 95% confidence interval = 0.63, 1.08) and lower cumulative risk (6.6 vs 9.2 cases per million persons, P = .012) of GBS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest that at the end of the influenza season cumulative GBS risk was less among the pH1N1vaccinated than the unvaccinated population, suggesting the benefit of vaccination as it relates to GBS. The observed potential protective effect on GBS attributed to vaccination warrants further study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vellozzi</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Claudia Vellozzi, Shahed Iqbal, Brock Stewart, and Frank DeStefano are with the Immunization Safety Office, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA. Jerome Tokars is with the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Shahed</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Brock</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Tokars</LastName><ForeName>Jerome</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>DeStefano</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Public Health</MedlineTA><NlmUniqueID>1254074</NlmUniqueID><ISSNLinking>0090-0036</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015993" MajorTopicYN="N">Life Tables</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24524517</ArticleId><ArticleId IdType="doi">10.2105/AJPH.2013.301651</ArticleId><ArticleId IdType="pmc">PMC4025712</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>N Engl J Med. 1998 Dec 17;339(25):1797-802</Citation><ArticleIdList><ArticleId IdType="pubmed">9854114</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2009 Jan 1;48(1):48-56</Citation><ArticleIdList><ArticleId IdType="pubmed">19025491</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1</Citation><ArticleIdList><ArticleId IdType="pubmed">19816398</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 2006 Nov 13;166(20):2217-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17101939</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Allergy Asthma Rep. 2011 Jun;11(3):197-204</Citation><ArticleIdList><ArticleId IdType="pubmed">21451970</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1979 Aug;110(2):105-23</Citation><ArticleIdList><ArticleId IdType="pubmed">463869</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2003 Jul 15;37(2):307-10</Citation><ArticleIdList><ArticleId IdType="pubmed">12856224</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2009 Feb 1;169(3):382-8</Citation><ArticleIdList><ArticleId IdType="pubmed">19033158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2010 Sep;10(9):643-51</Citation><ArticleIdList><ArticleId IdType="pubmed">20797646</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2007 Apr 04;2(4):e344</Citation><ArticleIdList><ArticleId IdType="pubmed">17406668</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2012 Jun 14;366(24):2294-304</Citation><ArticleIdList><ArticleId IdType="pubmed">22694000</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Jun;12(6):990-3</Citation><ArticleIdList><ArticleId IdType="pubmed">16707059</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 2012;39(2):109-15</Citation><ArticleIdList><ArticleId IdType="pubmed">22846726</ArticleId></ArticleIdList></Reference><Reference><Citation>Acad Emerg Med. 2005 Apr;12(4):360-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15805329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1981;9 Suppl:31-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7224614</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 2011;36(2):123-33</Citation><ArticleIdList><ArticleId IdType="pubmed">21422765</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2010 Jun 4;59(21):657-61</Citation><ArticleIdList><ArticleId IdType="pubmed">20520590</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2012 Jul 11;308(2):175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22782419</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2012 Jun 1;175(11):1100-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22582210</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Jan 10;29(3):599-612</Citation><ArticleIdList><ArticleId IdType="pubmed">20600491</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(8):e23085</Citation><ArticleIdList><ArticleId IdType="pubmed">21857999</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2010 Jul 30;59(29):901-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20671661</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2011 Aug 1;174(3):326-35</Citation><ArticleIdList><ArticleId IdType="pubmed">21652600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatrics. 2011 May;127 Suppl 1:S78-86</Citation><ArticleIdList><ArticleId IdType="pubmed">21502251</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2006 Dec;12(12):1880-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17326939</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Oct 19;29(45):7878-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21875631</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2012 Jun 1;175(11):1110-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22582209</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2010 Jan 22;59(2):44-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20094027</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacoepidemiol Drug Saf. 2012 May;21(5):546-52</Citation><ArticleIdList><ArticleId IdType="pubmed">22407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Oct 18;28(44):7161-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20804804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2005 Nov 5;366(9497):1653-66</Citation><ArticleIdList><ArticleId IdType="pubmed">16271648</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2011 Jul 12;343:d3908</Citation><ArticleIdList><ArticleId IdType="pubmed">21750072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000875 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000875 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24524517
|texte= Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24524517" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |